MIS-C Review Finds Severe Symptoms, Low Fatality Rate
A review of approximately 1000 children with multisystem inflammatory syndrome (MIS-C) from SARS-Cov-2 finds low fatality with aggressive treatment.
CDC to Begin Public Health Measures to Respond to Ebola in Africa
Beginning this week, the agency is funneling air travelers from 2 African countries to a limited amount of US airports.
The Philippines Begins Vaccination Program Amid Public Distrust
Prime Minister Narendra Modi of India receives vaccine as country begins next phase of program.
COVID-19 Research Contributions from AAAAI 2021
Courtesy of HCPLive, here's a look at 3 new pandemic talking points covered at the annual allergy and asthma meeting.
New COVID-19 Variant Identified in New York
The variant, B.1.526, was first found in samples dating back to November.
A Third of COVID-19 Patients Report Persistent Symptoms 6 Months After Illness
Symptoms of COVID-19 can persist for months in about a third of cases, including among those with mild illness, a new study confirms.
FDA Authorizes Janssen COVID-19 Vaccine in the US
The VRBPAC voted 22-0 with no abstentions to support the benefit-risk profile associated with Ad26.COV2.S on Friday night.
Vitamin B6 May Help With COVID-19 Cytokine Storm
Vitamin B6 is a water-soluble vitamin found in various foods such as fish, whole grains, and bananas.
FDA VRBPAC Votes in Favor to Recommend EUA of Janssen’s COVID-19 Vaccine
The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation paves the way for the authorization.
Over Half of COVID-19 Hospitalizations Due to 4 Conditions
Patients with cardiometabolic conditions have a high risk of poor outcomes.
Canada Authorizes AstraZeneca’s COVID-19 Vaccine
The country has no domestic production, and the government has been accused of not acquiring doses quickly enough.
SARS-CoV-2 Sequencing in the US: The Need for Collaboration
A team of cross-country investigators discuss their coordinated tracking of a new variant in the US earlier this year.
Interleukin-6 Receptor Antagonists Improve Outcomes in Severe COVID-19
Multiple observational and ex-vivo laboratory studies have demonstrated that IL-6 is an important cytokine associated with disease severity and mortality.
FDA Eases Temperature Requirements for Pfizer, BioNTech's COVID-19 Vaccine
If approved, the decision could have a significant impact on the mass vaccination programs.
RA Monoclonal Antibody Does Not Meet Primary Endpoint In COVID-19 Pneumonia Patients
In a phase 3 study, rheumatoid arthritis (RA) therapy, tocilizumab, did not improve clinical status or lower mortality in these patients.
New Pooled Testing Strategies can Better Identify COVID-19
Pooled testing allows multiple samples to be processed at once and help increase testing efficiency.
Minorities Are Underrepresented in Vaccine Clinical Trials
Vaccine clinical trials have fallen short of diversity guidelines during the past decade, with minority groups underrepresented and key data missing in many trials, a new study found.
Pfizer-BioNTech Evaluating Third COVID-19 Vaccine Dose for Variants
The new trial comes at a time when the FDA has provided guidance on navigating immunogenicity trials for vaccines designed against more transmissible SARS-CoV-2 strains.
Children Not Super Spreaders of SARS-CoV-2
Study results highlight that new data is constantly emerging and that society must be flexible in its response to the pandemic.
Israel Data Show Real-World Efficacy with Pfizer COVID-19 Vaccine
A massive assessment of a quickly vaccinated population shows the mRNA vaccine provides greater protection over time.
Model Developed Estimates COVID-19 Test False-Negative Rate
Not every positive patient missed by PCR and antigen tests will be infectious to others.
COVID-19 During Pregnancy Shows no Link With Death of Baby or Still Birth
The data supports strong guidance for enhanced precautions to prevent SARS‐CoV‐2 infection in pregnancy.
SOFA Score Insufficient for Predicting COVID-19 Mortality Before Intubation
A better option is needed that can incorporate specific mortality-related variables, the study authors said.
Janssen COVID-19 Vaccine Shows Benefit at 14, 28 Days in Phase 3 Data
Supporting EUA data for the one-shot vaccine candidate showed Americans fared best in a 40,000-participant, international trial.
Comparing Pediatric Hospitalizations Pre and Post COVID
Investigators sought to compare trends in US pediatric hospitalizations in 2020 with those the decade prior to COVID-19.
The Future Fight of HIV
A talk on optimistic, but pragmatic hopes for HIV cure and vaccine research, led by federal-level experts.
FDA Grants Priority Review to Possibly First TBE Vaccine from Pfizer
TicoVac will be decided on for both pediatric and adult people at risk of the tick-borne virus in August.
Tricking the Coronavirus With Peptides
SAP1 and SAP6 were found to inhibit a SARS-CoV-2 infection.
COVID-19 Outcomes Influenced by Antibody Response
Understanding underlying immunological mechanisms can provide critical insights.
FDA Announces Recall of Soft Cheese as Listeria Outbreak Sickens 7
In addition to 7 people in 4 states who have become sick after eating queso fresco from a New Jersey-based company, the Food and Drug Administration (FDA) has published an updated warning.